These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37549269)

  • 1. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
    Wang Z; Petricca J; Liu M; Zhang S; Chen S; Li M; Besschetnova A; Patalano S; Venkataramani K; Siegfried KR; Macoska JA; Han D; Gao S; Vedadi M; Arrowsmith CH; He HH; Cai C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2220472120. PubMed ID: 37549269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.
    Li M; Liu M; Han W; Wang Z; Han D; Patalano S; Macoska JA; Balk SP; He HH; Corey E; Gao S; Cai C
    Cancer Res; 2023 May; 83(10):1684-1698. PubMed ID: 36877164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
    Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
    Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.
    Jones D; Wade M; Nakjang S; Chaytor L; Grey J; Robson CN; Gaughan L
    Oncotarget; 2015 Oct; 6(30):29782-94. PubMed ID: 26336819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
    Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition.
    Han W; Liu M; Han D; Li M; Toure AA; Wang Z; Besschetnova A; Patalano S; Macoska JA; Gao S; He HH; Cai C
    Oncogene; 2022 Feb; 41(6):852-864. PubMed ID: 34975152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
    Hankey W; Chen Z; Wang Q
    Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.
    Cai C; He HH; Gao S; Chen S; Yu Z; Gao Y; Chen S; Chen MW; Zhang J; Ahmed M; Wang Y; Metzger E; Schüle R; Liu XS; Brown M; Balk SP
    Cell Rep; 2014 Dec; 9(5):1618-1627. PubMed ID: 25482560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.
    Mukhopadhyay NK; Kim J; You S; Morello M; Hager MH; Huang WC; Ramachandran A; Yang J; Cinar B; Rubin MA; Adam RM; Oesterreich S; Di Vizio D; Freeman MR
    Oncogene; 2014 Jun; 33(25):3235-45. PubMed ID: 23893242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.
    Wang Z; Townley SL; Zhang S; Liu M; Li M; Labaf M; Patalano S; Venkataramani K; Siegfried KR; Macoska JA; Han D; Gao S; Risbridger GP; Taylor RA; Lawrence MG; He HH; Selth LA; Cai C
    Nat Commun; 2024 Jun; 15(1):4914. PubMed ID: 38851846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
    Jin HJ; Zhao JC; Wu L; Kim J; Yu J
    Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells.
    Choi H; Lee SH; Um SJ; Kim EJ
    Cancer Lett; 2016 Jul; 376(2):360-6. PubMed ID: 27085459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression.
    Song H; Chu JW; Park SC; Im H; Park IG; Kim H; Lee JM
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide.
    Li J; Hong Z; Zhang J; Zheng S; Wan F; Liu Z; Dai B
    Oncogene; 2024 Mar; 43(10):744-757. PubMed ID: 38243079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.
    Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.
    Lupien M; Eeckhoute J; Meyer CA; Wang Q; Zhang Y; Li W; Carroll JS; Liu XS; Brown M
    Cell; 2008 Mar; 132(6):958-70. PubMed ID: 18358809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
    Besschetnova A; Han W; Liu M; Gao Y; Li M; Wang Z; Labaf M; Patalano S; Venkataramani K; Muriph RE; Macoska JA; Siegfried KR; Evans J; Balk SP; Gao S; Han D; Cai C
    Cancer Res Commun; 2023 Aug; 3(8):1716-1730. PubMed ID: 37663929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.